The new COVID-19 variant BA.3.2, popularly known as the “Cicada variant,” has recently attracted global attention due to its unusual re-emergence and mutation pattern. This variant belongs to the Omicron lineage of the SARS-CoV-2 virus and was first detected in South Africa in November 2024. After remaining relatively inactive for months, it resurfaced in late 2025 and has now been reported in over 23 countries.
One of the most significant aspects of BA.3.2 is its high number of mutations, especially in the spike protein. Scientists have identified nearly 70–75 mutations, which may increase transmissibility and help the virus partially evade immunity developed through vaccines or previous infections.
The symptoms of the BA.3.2 variant are largely similar to previous COVID-19 strains. However, a severe sore throat has been highlighted as a distinctive symptom. Other common symptoms include:
The BA.3.2 variant has been detected across multiple continents, including Europe, North America, Asia, and Africa. Surveillance data shows that it has been identified in travelers, clinical samples, and wastewater testing, indicating widespread but controlled circulation.
As of now, global health authorities have classified BA.3.2 as a “Variant Under Monitoring” rather than a “Variant of Concern.” Most reported cases are mild to moderate in severity. However, experts warn that it may spread more easily and cause reinfections, especially among vulnerable populations like the elderly and immunocompromised individuals.
Standard COVID-19 precautions remain effective against the BA.3.2 variant. These include:
Vaccines are still considered effective in preventing severe illness, hospitalization, and death.
The emergence of the BA.3.2 variant is highly relevant for aspirants preparing for government exams such as UPSC, SSC, Banking, Railways, Defence, and State PCS. Questions related to health emergencies, virus mutations, and global surveillance systems are frequently asked in current affairs sections. Understanding the classification of variants (Variant of Concern vs Variant Under Monitoring) is crucial for exam preparation.
This news highlights the importance of continuous global health monitoring and genomic surveillance. Even though the COVID-19 pandemic has reduced in intensity, the virus continues to evolve. Governments and health organizations must remain vigilant to prevent future outbreaks.
The BA.3.2 variant demonstrates how viruses mutate over time and adapt to immune defenses. This is important for students studying biology, public health, and science-related topics in exams.
The news also educates the public that not all variants are equally dangerous. While BA.3.2 is not currently severe, its mutation profile requires monitoring. This balanced understanding helps avoid panic while ensuring preparedness.
Since the outbreak of COVID-19 in 2019, the SARS-CoV-2 virus has continuously evolved. Major variants like Alpha, Delta, and Omicron have caused global waves of infection. Each variant emerged with specific mutations that influenced transmissibility and severity.
The Omicron variant, first identified in 2021, became dominant worldwide due to its high transmissibility. Over time, multiple subvariants emerged from Omicron, including BA.1, BA.2, and newer lineages like BA.3.2.
Organizations like the CDC and WHO have developed advanced genomic surveillance systems to track mutations. Techniques like wastewater monitoring and traveler-based testing have played a crucial role in early detection of variants like BA.3.2.
Previous COVID-19 waves highlighted the importance of vaccination, public awareness, and timely government response. These lessons continue to guide current strategies against emerging variants.
BA.3.2, also known as the “Cicada variant,” is a subvariant of the Omicron lineage of the COVID-19 virus. It has recently re-emerged globally and is being monitored due to its high mutation rate.
The nickname “Cicada” comes from its reappearance after a period of dormancy, similar to cicada insects that emerge after years underground.
The symptoms include severe sore throat, fever, dry cough, fatigue, nasal congestion, and headache. Most cases are mild to moderate.
Currently, it is not considered more dangerous. It is classified as a “Variant Under Monitoring,” meaning it is being observed but not yet a major threat.
It has around 70–75 mutations, particularly in the spike protein, which may impact transmissibility and immune escape.
Yes, existing vaccines are still effective in preventing severe illness, hospitalization, and death.
Organizations like the World Health Organization (WHO) and CDC monitor and classify variants based on risk levels.
A Variant of Concern has proven higher risk (transmission/severity), while a Variant Under Monitoring is still being studied for its impact.
Bhargavastra Counter Drone System is India’s indigenous defence technology designed to tackle drone swarm threats.…
Majhi Kanya Bhagyashree Scheme 2025 provides financial support for girl children in Maharashtra. Know eligibility…
Uttarakhand Radio Collar Elephants Project aims to monitor elephant movements before Haridwar Kumbh 2027. Know…
Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY) is Maharashtra’s cashless health insurance scheme. Learn about…
Jagannath Dham Trademark Protection highlights Puri Jagannath Temple’s initiative to secure sacred names and symbols…
Mirabai Chanu Commonwealth Games Gold achievement marks her third consecutive Commonwealth Games title. Learn about…